Synonyms:

1,3,5-Triazin-2(1H)-one, 4-aMino-1-β-D-ribofuranosyl-;4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
Ladakamycin;Azacitidine(5-Azacitidine);Azacitidine(Vidaza);4-aMino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;Azacitidine (150 mg);4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1,3,5-triazin-2;4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
Ladakamycin

Canonical SMILES: C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N

HS Code: 29349990

Density:1.4287(roughestimate)

Boiling Point:387.12°C(roughestimate)

Refractive Index:1.6590(estimate)

Melting Point: 226-232 °C(dec.)(lit.)

alpha: 40o(C=1,H2O22oC)

Storage: 2-8°C

PKA: 13.46±0.70(Predicted)

Appearance: lyophilizedpowder

Hazard Codes: T

Risk Statements:  45-46-22

Safety Statements: 53-22-36/37/39-45

WGK Germany: 3